financetom
Business
financetom
/
Business
/
Broadcom Expected to Face Slowdown in Fiscal Q4 Amid ASIC Challenges, Morgan Stanley Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Broadcom Expected to Face Slowdown in Fiscal Q4 Amid ASIC Challenges, Morgan Stanley Says
Dec 9, 2024 8:28 AM

11:10 AM EST, 12/09/2024 (MT Newswires) -- Broadcom ( AVGO ) fiscal Q4 earnings are expected to meet guidance but not exceed it given a slowdown in the transition to Tensor Processing Unit version 6 that impacted the application-specific integrated circuit business, Morgan Stanley said in an earnings preview Monday.

The company remains well-positioned for long-term growth in artificial intelligence and AI-related revenue is projected to grow from $12 billion in fiscal 2024 to $15 billion in fiscal 2025, with faster growth in net growth in networking versus ASICs, according to the note.

ASIC business is facing near-term challenges, including slower customer ramp-ups and the concentrated nature of its customer base, Morgan Stanley said. However, its superior design capabilities and intellectual property create a strong competitive moat, especially against Asian competitors.

Morgan Stanley also said that Broadcom's ( AVGO ) enterprise and storage semiconductor businesses are recovering from a recent downturn, while the wireless segment faces challenges due to the impact of Apple's ( AAPL ) potential shift away from its Wi-Fi combo chip.

The brokerage has an overweight rating on the stock, with a $180 price target.

Price: 179.05, Change: -0.48, Percent Change: -0.27

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bloom Energy Insider Sold Shares Worth $2,825,600, According to a Recent SEC Filing
Bloom Energy Insider Sold Shares Worth $2,825,600, According to a Recent SEC Filing
Nov 10, 2025
03:42 AM EST, 11/10/2025 (MT Newswires) -- Eddy Zervigon, Director, on November 05, 2025, sold 20,000 shares in Bloom Energy ( BE ) for $2,825,600. Following the Form 4 filing with the SEC, Zervigon has control over a total of 67,161 Class A common shares of the company, with 61,161 shares held directly and 6,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1664703/000119312525272821/xslF345X05/ownership.xml...
QuantumScape Insider Sold Shares Worth $2,660,415, According to a Recent SEC Filing
QuantumScape Insider Sold Shares Worth $2,660,415, According to a Recent SEC Filing
Nov 10, 2025
03:44 AM EST, 11/10/2025 (MT Newswires) -- Jeffrey B Straubel, Director, on November 05, 2025, sold 157,171 shares in QuantumScape ( QS ) for $2,660,415. Following the Form 4 filing with the SEC, Straubel has control over a total of 293,934 Class A common shares of the company, with 293,934 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1811414/000149472725000010/xslF345X05/primarydocument.xml ...
Rumble Q3 Loss Narrows, Revenue Decreases; Agrees to All-Stock Acquisition of Northern Data
Rumble Q3 Loss Narrows, Revenue Decreases; Agrees to All-Stock Acquisition of Northern Data
Nov 10, 2025
03:43 AM EST, 11/10/2025 (MT Newswires) -- Rumble (RUM) reported a Q3 loss Monday of $0.06 per diluted share, narrowing from a loss of $0.15 a year earlier. Three analysts polled by FactSet expected a loss of $0.06. Revenue for the quarter ended Sept. 30 was $24.8 million, down from $25.1 million a year earlier. Three analysts surveyed by FactSet...
Novo Nordisk shares rise after dropping Metsera bid
Novo Nordisk shares rise after dropping Metsera bid
Nov 10, 2025
COPENHAGEN (Reuters) -Shares in Novo Nordisk rose in early trade on Monday, after the Wegovy-maker on Saturday dropped its bid for U.S. weight loss drug company Metsera ( MTSR ), ending a bidding war with rival Pfizer ( PFE ). Novo's shares traded 2.9% higher at 0801 GMT. U.S. drugmaker Pfizer ( PFE ) said late on Friday it had...
Copyright 2023-2026 - www.financetom.com All Rights Reserved